Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Kairos Pharma Ltd.
AI Executive Summary
AI-powered analysis of 8-K filing content
Kairos Pharma Ltd. held its 2026 annual stockholder meeting on June 29, 2026, with 62.81% share participation (13.45M of 21.41M shares). The meeting included voting on five proposals, including director elections, which will influence the company's future governance and strategic direction.
Key Takeaways
Annual meeting held on June 29, 2026 with strong shareholder participation at 62.81% of eligible shares
Five proposals were voted on, including director elections that will shape future company leadership
2 more takeaways